China To Issue New Rules On Adverse Event Reporting To Enhance Surveillance
This article was originally published in The Pink Sheet Daily
Executive Summary
Under the draft regulation, the definition of SAE is completely in line with the U.S. FDA's definition, reporting is required when there is any suspicion that the safety event is drug related, and marketing authorization can be revoked.